Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-09-015372
Filing Date
2009-03-12
Accepted
2009-03-12 16:55:38
Documents
1
Period of Report
2009-03-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 JER rrd237266.html 4  
1 FORM 4 JER rrd237266.xml 4 7464
  Complete submission text file 0001181431-09-015372.txt   9262
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O IMMUCELL CORP 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 2078782770
ROTHSCHILD JONATHAN E (Reporting) CIK: 0001043218 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 09676374